Arpeggio Biosciences

Arpeggio Biosciences
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development. We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
Location: United States, Colorado, Boulder
Member count: 1-10
Total raised: $20.2M
Founded date: 2017

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
07.09.2022Series A$

Mentions in press and media 3

07.09.2022Arpeggio B...How can drug developers design...--medcitynew...
07.09.2022Arpeggio B...Arpeggio Biosciences, a
15.01.2020Arpeggio B...Arpeggio Bio , a Boulder,